Navigation Links
Hepatitis C Screening Program in Wales

The National Public Health Service for Wales (NPHS) has announced that the actual risk of anyone contacting Hepatitis C was very rare after a caseworker was apparently diagnosed with the disease in a dental surgery. Around 5,500 patients in Gwynedd are to be screened for the virus.//

"The team has assessed the risk to patients and is preparing a comprehensive communications strategy to contact patients who have been treated by the healthcare worker," a statement released by the NPHS said. "The risk of patients contacting hepatitis C is very small and the contact programme is being taken on a precautionary basis."

Hepatitis C is the infection or inflammation of the liver and is caused by a blood-borne virus. The disease is very contagious and spreads when blood of an infected person enters into the bloodstream of another. Some of the symptoms of the disease are fatigue, weight loss, nausea, 'flu-like symptoms, problems concentrating, abdominal pain and jaundice.

"The danger is certainly very slight, but assuming this is just an infected worker, there's no reason why in a dental surgery their blood should be spilt onto your blood and get into your system," said Charles Gore, chief executive of the Hepatitis C Trust. "Nonetheless, it's a very sensible precaution to screen everyone".

He added that even if anyone was infected there was adequate treatment available. "In a worst case scenario, if someone was infected, there is now very effective treatment available, particularly effective if the diagnosis is early and is caught in the first six months," he said. "Although this is a very serious disease, there's a lot that can be done about it and in this case, the risk is going to be very small".


'"/>




Page: 1

Related medicine news :

1. Vitamin B for Hepatitis
2. Hepatitis G May Boost HIV Survival
3. Cure for Hepatitis B
4. Hepatitis E virus made impotent
5. Sharing injection equipment spreads Hepatitis C
6. Lymphomas Link to Hepatitis C
7. Hepatitis shots is promising
8. Need for Hepatitis Booster Questioned
9. Good News for HIV Patients Also Suffering From Hepatitis C Virus
10. The Link Between Hepatitis B Vaccine And Multiple Sclerosis Questioned
11. The Effectiveness Of Hepatitis B Vaccine Questioned
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, ... and his M.D from the David Geffen School of Medicine at UCLA. He trained ... Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where ...
(Date:6/24/2016)... Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... surgery procedures that most people are unfamiliar with. The article goes on to state ... procedures, but also many of these less common operations such as calf and cheek ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Sessions in Dallas that it will receive two significant new grants to support ... as PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists ...
(Date:6/24/2016)... ... ... of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum Wage’ ... 2020 and then adjusting it yearly to increase at the same rate as the median ... floor does not erode again, and make future increases more predictable. , The company is ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® ... Group (TGIG), has initiated cultivation and processing operations at its production facility, and ... Nevada. , Puradigm is the manufacturer of a complete system of proactive air ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- Research and Markets has announced the addition ... 2022" report to their offering. ... with kidney failure, it replaces the function of kidneys by ... and thus the treatment helps to keep the patient body,s ... Increasing number of ESRD patients & substantial healthcare ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it ... (procalcitonin) assay as a dedicated testing solution for people ... Roche is the first IVD company in the U.S ... assessment and management. PCT is a sepsis-specific ... blood can aid clinicians in assessing the risk of ...
Breaking Medicine Technology: